Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain

Microbes and Infection

Volumn 5, Issue 2, 2003, Pages 135-142

  Elkins, Karen L ^a   Cowley, Siobhán C ^a   Bosio, Catharine M ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

B lymphocytes; Bacterial vaccines; Francisella tularensis; Immunity, natural; Interferon type II; Mice; T lymphocytes

Indexed keywords

BACTERIAL VACCINE; CYTOKINE; LIVE VACCINE;

ANIMAL MODEL; BIOLOGICAL WARFARE; FRANCISELLA TULARENSIS; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TULAREMIA;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; DISEASE MODELS, ANIMAL; FRANCISELLA TULARENSIS; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, KNOCKOUT; TULAREMIA; VACCINATION; VACCINES, ATTENUATED;

BACTERIA (MICROORGANISMS); FRANCISELLA; FRANCISELLA TULARENSIS;

EID: 0037297290     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(02)00084-9     Document Type: Review

References (44)

1. Francis E. A summary of the present knowledge of tularemia. Medicine. 7:1928;411-426.
2. Elkins K.L., Nano F.E. Sussman M. Molecular Medical Microbiology. 2001;Academic Press, UK.
3. Tärnvik A. Nature of protective immunity to Francisella tularensis. Rev. Infect. Dis. 11:1989;440-451.
4. Sandström G. The tularemia vaccine. J. Chem. Technol. Biotechnol. 59:1994;315-320.
5. Tärnvik A., Eriksson M., Sandström G., Sjöstedt A. Francisella tularensis-a model for studies of the immune response to intracellular bacteria in man. Immunology. 76:1992;349-354.
6. Eigelsbach H.T., Downs C.M. Prophylactic effectiveness of live and killed tularemia vaccines. J. Immunol. 87:1961;415-425.
7. Fortier A.H., Slayter M.V., Ziemba R., Meltzer M.S., Nacy C.A. Live vaccine strain of Francisella tularensis: infection and immunity in mice. Infect. Immun. 59:1991;2922-2928.
8. Elkins K.L., Winegar R.K., Nacy C.A., Fortier A.H. Introduction of Francisella tularensis at skin sites induces resistance to infection and generation of protective immunity. Microb. Pathogen. 13:1992;417-421.
9. Elkins K.L., Rhinehart-Jones T.R., Culkin S.J., Yee D., Winegar R.K. Minimal requirements for murine resistance to infection with Francisella tularensis LVS. Infect. Immun. 64:1996;3288-3293.
10. Elkins K.L., Rhinehart-Jones T., Nacy C.A., Winegar R.K., Fortier A.H. T-cell-independent resistance to infection and generation of immunity to Francisella tularensis. Infect. Immun. 61:1993;823-829.
11. + T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS. J. Immunol. 157:1996;5042-5048.
12. Leiby D.A., Fortier A.H., Crawford R.M., Schreiber R.D., Nacy C.A. In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodies. Infect. Immun. 60:1992;84-89.
13. Anthony L.S.D., Ghadirian E., Nestel F.P., Kongshavn P.A.L. The requirement for gamma interferon in resistance of mice to experimental tularemia. Microb. Pathogen. 7:1989;421-428.
14. Ottenhoff T.H., Kumararatne D., Casanova J.L. Novel immunodeficiencies reveal the essential role of type 1 cytokines in immunity to intracellular bacteria. Immunol. Today. 19:1998;491-494.
15. Fortier A.H., Polsinelli T., Green S.J., Nacy C.A. Activation of macrophages for destruction of Francisella tularensis: identification of cytokines, effector cells, and effector molecules. Infect. Immun. 60:1992;817-825.
16. Anthony L.S.D., Morrissey P.J., Nano F.E. Growth inhibition of Francisella tularensis live vaccine strain by IFN-gamma-activated macrophages is mediated by reactive nitrogen intermediates derived from l-arginine metabolism. J. Immunol. 148:1992;1829-1834.
17. Elkins K.L., Cooper A., Colombini S.M., Cowley S.C., Kieffer T.L. In vivo clearance of an intracellular bacterium, Francisella tularensis LVS, is dependent on the p40 subunit of interleukin-12 (IL-12) but not on IL-12 p70. Infect. Immun. 70:2002;1936-1948.
18. Fortier A.H., Leiby D.A., Narayanan R.B., Asafoadjei E., Crawford R.M., Nacy C.A., Meltzer M.S. Growth of Francisella tularensis LVS in macrophages: the acidic intracellular compartment provides essential iron required for growth. Infect. Immun. 63:1995;1478-1483.
19. Anthony L.S.D., Burke R.D., Nano F.E. Growth of Francisella spp. in rodent macrophages. Infect. Immun. 59:1991;3291-3296.
20. Bosio C.M., Elkins K.L. Susceptibility to secondary Francisella tularensis LVS infection in B cell deficient mice is associated with neutrophilia but not with defects in specific T cell mediated immunity. Infect. Immun. 69:2001;194-203.
21. Lai X.H., Golovliov I., Sjöstedt A. Francisella tularensis induces cytopathogenicity and apoptosis in murine macrophages via a mechanism that requires intracellular bacterial multiplication. Infect. Immun. 69:2001;4691-4694.
22. Polsinelli T., Meltzer M.S., Fortier A.H. Nitric oxide-independent killing of Francisella tularensis by IFN-γ-stimulated murine alveolar macrophages. J. Immunol. 153:1994;1238-1245.
23. Golovliov I., Ericsson M., Sandström G., Tärnvik A., Sjöstedt A. Identification of proteins of Francisella tularensis induced during growth in macrophages and cloning of the gene encoding a prominently induced 23-kilodalton protein. Infect. Immun. 65:1997;2183-2189.
24. Gray C.G., Cowley S.C., Cheung K.K.M., Nano F.E. The identification of five genetic loci of Francisella associated with intramacrophage growth. FEMS Microbiol. Lett. 215:2002;53-56.
25. Baron G.S., Nano F.E. MglA and MglB are required for the intramacrophage growth of Francisella novicida. Mol. Microbiol. 29:1998;247-259.
26. Sjöstedt A., Conlan J.W., North R.J. Neutrophils are critical for host defense against primary infection with the facultative intracellular bacterium Francisella tularensis in mice and participate in defense against reinfection. Infect. Immun. 62:1994;2779-2783.
27. Conlan J.W., North R.J. Early pathogenesis of infection in the liver with the facultative intracellular bacteria Listeria monocytogenes, Francisella tularensis, and Salmonella typhimurium involves lysis of infected hepatocytes by leukocytes. Infect. Immun. 60:1992;5164-5171.
28. Kovarova H., Hernychova L., Hajduch M., Sirova M., Macela A. Influence of the bcg locus on natural resistance to primary infection with the facultative intracellular bacterium Francisella tularensis in mice. Infect. Immun. 68:2000;1480-1484.
29. Dreisbach V.C., Cowley S., Elkins K.L. Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and gamma interferon. Infect. Immun. 68:2000;1988-1996.
30. Elkins K.L., Leiby D.A., Winegar R.K., Nacy C.A., Fortier A.H. Rapid generation of specific protective immunity to Francisella tularensis. Infect. Immun. 60:1992;4571-4577.
31. Culkin S.J., Rhinehart-Jones T., Elkins K.L. A novel role for B cells in early protective immunity to an intracellular pathogen, Francisella tularensis strain LVS. J. Immunol. 158:1997;3277-3284.
32. Elkins K.L., Rhinehart-Jones T.R., Stibitz S., Conover J.S., Klinman D.M. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J. Immunol. 162:1999;2291-2298.
33. Ancuta P., Pedron R., Girard R., Sandström G., Chaby R. Inability of the Francisella tularensis lipopolysaccharide to mimic or to antagonize the induction of cell activation by endotoxins. Infect. Immun. 64:1996;2041-2046.
34. Sandström G., Sjöstedt A., Johansson T., Kuoppa K., Williams J.C. Immunogenicity and toxicity of lipopolysaccharide from Francisella tularensis LVS. FEMS Microbiol. Immunol. 105:1992;201-210.
35. Rhinehart-Jones T.R., Fortier A.H., Elkins K.L. Transfer of immunity against lethal murine Francisella infection by specific antibody depends on host gamma interferon and T cells. Infect. Immun. 62:1994;3129-3137.
36. Anthony L.S.D., Kongshavn P.A.L. Experimental murine tularemia caused by Francisella tularensis, live vaccine strain: a model of acquired cellular resistance. Microb. Pathogen. 2:1987;3-14.
37. Conlan J.W., Shen H., Webb A., Perry M.B. Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of the pathogen. Vaccine. 20:2002;3465-3471.
38. Saslaw S., Eigelbach H.T., Wilson H.E., Prior J.A., Carhart S. Tularemia vaccine study. I. Intracutaneous challenge. Arch. Intern. M. 107:1961;121-133.
39. Elkins K.L., Bosio C.M., Rhinehart-Jones T.R. Importance of B cells, but not specific antibodies, in primary and secondary protective immunity to the model intracellular bacterium, Francisella tularensis live vaccine strain. Infect. Immun. 67:1999;6002-6007.
40. + T-cell-dependent and-independent host defense mechanisms can operate to control and resolve primary and secondary Francisella tularensis LVS infection in mice. Infect. Immun. 62:1994;5603-5607.
41. + T cells of primed humans. Immunology. 76:1992;584-592.
42. Poquet Y., Kroca M., Halary F., Stenmark S., Peyrat M.A., Bonneville M., Fournie J.J., Sjöstedt A. Expansion of Vgamma9 Vdelta2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination. Infect. Immun. 66:1998;2107-2114.
43. Anthony L.S.D., Kongshavn P.A.L. H-2 restriction in acquired cell-mediated immunity to infection with Francisella tularensis LVS. Infect. Immun. 56:1988;452-456.
44. Sjöstedt A., North R.J., Conlan J.W. The requirement of tumour necrosis factor-alpha and interferon-gamma for the expression of protective immunity to secondary murine tularaemia depends on the size of the challenge inoculum. Microbiology. 142:1996;1369-1374.